4.6 Article

COVID-19 Infection: Implications for Perioperative and Critical Care Physicians

期刊

ANESTHESIOLOGY
卷 132, 期 6, 页码 1346-1361

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ALN.0000000000003303

关键词

-

向作者/读者索取更多资源

Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or mild illness to hypoxemic respiratory failure or multisystem organ failure, necessitating intubation and intensive care management. Healthcare providers, and particularly anesthesiologists, are at the frontline of this epidemic, and they need to be aware of the best available evidence to guide therapeutic management of patients with COVID-19 and to keep themselves safe while doing so. Here, the authors review COVID-19 pathogenesis, presentation, diagnosis, and potential therapeutics, with a focus on management of COVID-19-associated respiratory failure. The authors draw on literature from other viral epidemics, treatment of acute respiratory distress syndrome, and recent publications on COVID-19, as well as guidelines from major health organizations. This review provides a comprehensive summary of the evidence currently available to guide management of critically ill patients with COVID-19.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Primary graft dysfunction attenuates improvements in health-related quality of life after lung transplantation, but not disability or depression

Nicholas A. Kolaitis, Ying Gao, Allison Soong, John R. Greenland, Steven R. Hays, Jeffrey Golden, Lorriana E. Leard, Rupal J. Shah, Mary Ellen Kleinhenz, Patricia P. Katz, Aida Venado, Jasleen Kukreja, Paul D. Blanc, Jonathan P. Singer

Summary: Disability, depressive symptoms, and impaired health-related quality of life are common among patients with life-threatening respiratory compromise. Primary graft dysfunction (PGD) may attenuate improvements in patient-reported outcomes after lung transplantation, with patients experiencing improvements in various aspects of HRQL regardless of PGD severity. However, those with PGD Grade 3 showed lower improvement in generic-physical HRQL and health-utility compared to other participants. These findings highlight the ongoing impact of PGD on patient-reported outcomes post-transplantation and the need for further interventions.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature

Daniel T. Dugger, Monica Fung, Steven R. Hays, Jonathan P. Singer, Mary E. Kleinhenz, Lorriana E. Leard, Jeffrey A. Golden, Rupal J. Shah, Joyce S. Lee, Fred Deiter, Nancy Y. Greenland, Kirk D. Jones, Chaz R. Langelier, John R. Greenland

Summary: In patients with chronic lung allograft dysfunction (CLAD) following lung transplantation, research indicated that small airway gene expression changes were associated with CLAD, and molecular analysis conducted on airway brushings showed potential for diagnosing CLAD.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction

Carlo J. Iasella, Aki Hoji, Iulia Popescu, Jianxin Wei, Mark E. Snyder, Yingze Zhang, Wei Xu, Vera Iouchmanov, Ritchie Koshy, Mark Brown, Monica Fung, Charles Langelier, Elizabeth A. Lendermon, Daniel Dugger, Rupal Shah, Joyce Lee, Bruce Johnson, Jeffrey Golden, Lorriana E. Leard, Mary Ellen Kleinhenz, Silpa Kilaru, Steven R. Hays, Jonathan P. Singer, Pablo G. Sanchez, Matthew R. Morrell, Joseph M. Pilewski, John R. Greenland, Kong Chen, John F. McDyer

Summary: Chronic lung allograft dysfunction (CLAD) is a major complication limiting long-term survival among lung transplant recipients, and the airway transcriptome may reflect key immunologic changes in the disease.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Surgery

Frailty and aging-associated syndromes in lung transplant candidates and recipients

Joanna M. Schaenman, Joshua M. Diamond, John R. Greenland, Cynthia Gries, Cassie C. Kennedy, Amit D. Parulekar, Dmitry Rozenberg, Jonathan P. Singer, Lianne G. Singer, Laurie D. Snyder, Sangeeta Bhorade

Summary: Older and frailer lung transplant candidates are at increased risk for mortality. Evaluation of elderly and frail candidates is essential, as frailty is commonly associated with adverse outcomes in lung transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

The association of post-operative delirium with patient-reported outcomes and mortality after lung transplantation

Claire L. DeBolt, Ying Gao, Nicole Sutter, Allison Soong, Lorriana Leard, Golden Jeffrey, Mary Ellen Kleinhenz, Daniel Calabrese, John Greenland, Aida Venado, Steven R. Hays, Rupal Shah, Jasleen Kukreja, Binh Trinh, Nicholas A. Kolaitis, Vanja Douglas, Joshua M. Diamond, Patrick Smith, Jonathan Singer

Summary: Post-operative delirium after lung transplantation is common and associated with health-related quality of life and depressive symptoms. Delirium is linked to attenuated improvements in SF12-PCS but not SF12-MCS and GDS, and is also associated with an increased risk of mortality.

CLINICAL TRANSPLANTATION (2021)

Article Medicine, Research & Experimental

Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury

Daniel R. Calabrese, Emily Aminian, Benat Mallavia, Fengchun Liu, Simon J. Cleary, Oscar A. Aguilar, Ping Wang, Jonathan P. Singer, Steven R. Hays, Jeffrey A. Golden, Jasleen Kukreja, Daniel Dugger, Mary Nakamura, Lewis L. Lanier, Mark R. Looney, John R. Greenland

Summary: NK cells play a crucial role in pulmonary ischemia-reperfusion injury by binding to the NKG2D receptor. Therapies targeting NK cells may hold promise in acute lung injury.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Editorial Material Surgery

Molecular diagnostics for CLAD: When and where?

John R. Greenland, John F. McDyer

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Surgery

Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival

Nancy Y. Greenland, Fred Deiter, Daniel R. Calabrese, Steven R. Hays, Jasleen Kukreja, Lorriana E. Leard, Nicholas A. Kolaitis, Jeffrey A. Golden, Jonathan P. Singer, John R. Greenland

Summary: Inflammation in bronchoalveolar lavage (BAL) cytology can indicate acute rejection or infection, increasing the risk of chronic lung allograft dysfunction (CLAD) or death. However, the study also suggests that inflammation in BAL cytology does not provide additional information on CLAD-free survival risk beyond BAL cell counts.

CLINICAL TRANSPLANTATION (2022)

Editorial Material Cardiac & Cardiovascular Systems

HLA-G/ILT2 signaling on the path to tolerance

Ping Wang, John R. Greenland

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Respiratory System

Depressive symptoms in lung transplant recipients: trajectory and association with mortality and allograft dysfunction

Nicholas A. Kolaitis, Ying Gao, Allison Soong, John R. Greenland, Steven R. Hays, Jeffrey A. Golden, Aida Venado, Lorriana E. Leard, Rupal J. Shah, Mary Ellen Kleinhenz, Patricia P. Katz, Jasleen Kukreja, Paul D. Blanc, Patrick J. Smith, Jonathan Paul Singer

Summary: This study aimed to investigate the association between depressive symptoms over multiple assessments and allograft dysfunction and mortality following lung transplantation. The results showed that worsening depressive symptoms were associated with declines in lung function and increased mortality, highlighting depression as a modifiable risk factor for chronic lung allograft dysfunction and death.

THORAX (2022)

Article Cell Biology

Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans

Qizhi Tang, Joey Leung, Yani Peng, Alberto Sanchez-Fueyo, Juan-Jose Lozano, Alice Lam, Karim Lee, John R. Greenland, Marc Hellerstein, Mark Fitch, Kelvin W. Li, Jonathan H. Esensten, Amy L. Putnam, Angela Lares, Vinh Nguyen, Weihong Liu, Nancy D. Bridges, Jonah Odim, Anthony J. Demetris, Josh Levitsky, Timucin Taner, Sandy Feng

Summary: Promoting immune tolerance to transplanted organs can reduce the amount of immunosuppressive drugs needed, lowering risks. Testing showed the potential of autologous donor alloantigen-reactive T-reg therapy in inducing transplantation tolerance.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Surgery

CD16+natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction

Daniel R. Calabrese, Tiffany Chong, Jonathan P. Singer, Raja Rajalingam, Steven R. Hays, Jasleen Kukreja, Lorriana Leard, Jeffrey A. Golden, Lewis L. Lanier, John R. Greenland

Summary: Acute and chronic rejections limit the long-term survival after lung transplant. Pulmonary antibody-mediated rejection (AMR) is an incompletely understood driver of long-term outcomes characterized by donor-specific antibodies (DSAs), innate immune infiltration, and evidence of complement activation.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Article Surgery

The Intersection of Aging and Lung Transplantation: its Impact on Transplant Evaluation, Outcomes, and Clinical Care

Brittany Koons, Michaela R. Anderson, Patrick J. Smith, John R. Greenland, Jonathan P. Singer

Summary: Older adults, aged 65 and above, are the fastest growing age group undergoing lung transplantation. Emerging evidence suggests that measures of physiological age, such as frailty and neurocognitive function, may better predict poor transplant outcomes than chronological age. Efforts are needed to improve outcomes for this growing cohort of older lung transplant patients through better risk assessment and interventions targeting physiological aging.

CURRENT TRANSPLANTATION REPORTS (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Lung Transplant Recipients with Idiopathic Pulmonary Fibrosis and Telomere Dysfunction Have Impaired Donor-Specific Immune Responses

P. Wang, J. Leung, A. Lam, J. Lee, D. R. Calabrese, S. R. Hays, J. A. Golden, J. Kukreja, J. P. Singer, P. J. Wolters, Q. Tang, J. R. Greenland

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

Meeting Abstract Cardiac & Cardiovascular Systems

Natural Killer Cells Recognize Pulmonary Epithelial Stress Molecules during Primary Graft Dysfunction

E. Aminian, B. Mallavia, F. Liu, S. Cleary, P. Wang, J. P. Singer, S. R. Hays, J. A. Golden, J. Kukreja, D. Dugger, M. Nakamura, L. L. Lanier, M. R. Looney, J. R. Greenland, D. R. Calabrese

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)

暂无数据